A case of biopsy‐proven inflammatory dilated cardiomyopathy following heterologous mRNA‐1273 third‐dose immunization

A case of biopsy‐proven inflammatory dilated cardiomyopathy following heterologous mRNA‐1273 third‐dose immunization

Saved in:

Bibliographic Details
Main Authors:	Katsuya Hashimoto, Hiroyuki Yamamoto, Yoshihiko Ikeda, Jun Isogai, Toru Hashimoto
Format:	Article
Language:	English
Published:	Wiley 2024-12-01
Series:	ESC Heart Failure
Subjects:	corticosteroid treatment endomyocardial biopsy heterologous immunization inflammatory dilated cardiomyopathy mRNA‐1273 SARS‐CoV‐2 vaccine vaccine‐associated myocarditis
Online Access:	https://doi.org/10.1002/ehf2.14924
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Safety and immunogenicity of an mRNA-1273 vaccine booster in adolescents
by: Amparo L. Figueroa, et al.
Published: (2025-12-01)

No immunological interference or concerns about safety when seasonal quadrivalent influenza vaccine is co-administered with a COVID-19 mRNA-1273 booster vaccine in adults: A randomized trial
by: Abdi Naficy, et al.
Published: (2024-12-01)

Myocarditis following mRNA COVID‐19 vaccination: call for endomyocardial biopsy
by: Daniel Kiblboeck, et al.
Published: (2022-06-01)

mRNA-1273 COVID-19 vaccine induces CD4+ T-cell responses among solid organ transplant recipients
by: Bethany Girard, et al.
Published: (2025-04-01)

PRIMARY (GENETICALLY DETERMINED) DILATION CARDIOMYOPATHY IN A PATIENT WITH NOVEL MUTATION OF LAMIN GENE: CLINICAL AND MORPHOLOGICAL MANAGEMENT
by: O. V. Blagova, et al.
Published: (2017-08-01)

Heterologous vaccination with subunit protein vaccine induces a superior neutralizing capacity against BA.4/5‐included SARS‐CoV‐2 variants than homologous vaccination of mRNA vaccine
by: Dandan Peng, et al.
Published: (2023-04-01)

The role of intestinal microbiota in the humoral response to SARS-CoV-2 after mRNA-1273 vaccination
by: María Tarriño, et al.
Published: (2025-07-01)

CLINICAL AND MORPHOLOGICAL APPROACH TO DIAGNOSIS OF "IDIOPATHIC" ARRHYTHMIAS AND DILATED CARDIOMYOPATHY SYNDROME AS A BASIS FOR DIFFERENTIATED THERAPY. Part I (Diagnostics)
by: O. V. Blagova, et al.
Published: (2015-09-01)

MULTISPIRAL COMPUTED TOMOGRAPHY VERSUS MYOCARDIAL BIOPSY IN DIAGNOSTICS OF YOCARDITIS AND PROGNOSIS EVALUATION OF DILATION CARDIOMYOPATHY SYNDROME
by: I. N. Alieva, et al.
Published: (2017-02-01)

Hybrid versus vaccine immunity of mRNA-1273 among people living with HIV in East and Southern Africa: a prospective cohort analysis from the multicentre CoVPN 3008 (Ubuntu) studyResearch in context
by: Nigel Garrett, et al.
Published: (2025-02-01)

The New Era of mRNA Vaccines: The Success of the COVID-19 Vaccines and the Safety Concerns in Adolescents
by: Muthu Gopal, et al.
Published: (2025-05-01)

CLINICAL AND MORPHOLOGICAL APPROACH TO DIAGNOSIS OF "IDIOPATHIC" ARRHYTHMIAS AND DILATED CARDIOMYOPATHY SYNDROME AS A BASIS FOR DIFFERENTIATED THERAPY. Part II (Treatment)
by: O. V. Blagova, et al.
Published: (2015-09-01)

Ethical concerns regarding heterologous COVID-19 vaccine administration
by: Somsri Wiwanitkit, et al.
Published: (2024-12-01)

Heterologous prime-boost vaccination drives stromal activation and adaptive immunity against SARS-CoV-2 variants
by: Ji Hyang Jeon, et al.
Published: (2025-05-01)

Myocarditis Related-COVID-19 mRNA Vaccination: A Narrative Review
by: Idman Gushaendri, et al.
Published: (2023-06-01)

SARS-CoV-2 mRNA Vaccines Induce Cross-Reactive Antibodies to NL63 Coronavirus but Do Not Boost Pre-Existing Immunity Anti-NL63 Antibody Responses
by: Weiyi Tang, et al.
Published: (2025-03-01)

Durability of immune response against omicron BA.2 and BA.4/5 and T cell responses after boosting with mRNA and adenoviral vector-based vaccines following heterologous CoronaVac/ChAdOx-1nCov-19 vaccination
by: Nungruthai Suntronwong, et al.
Published: (2023-12-01)

Effectiveness of myocarditis therapy depending on the diagnosis approach (with or without myocardial biopsy)
by: O. V. Blagova, et al.
Published: (2021-05-01)

Dilated cardiomyopathy and myocarditis: a clinical case
by: O.V. Onyshchenko, et al.
Published: (2023-12-01)

Clinical Course, Outcomes, and Risk Factors of Myocarditis and Pericarditis Following Administration of mRNA-1273 Vaccination: A Protocol for a Federated Real-World Evidence Vaccine Safety Study Using Data from Five European Data Sources
by: Laura C. Zwiers, et al.
Published: (2025-07-01)

Characteristics and outcomes of adverse events after COVID‐19 vaccination
by: Tariq Kewan, et al.
Published: (2021-10-01)

Infectious-immune pericarditis: clinical assessment, diagnostics, and differentiated baseline therapy with hydroxychloroquine
by: O. V. Blagova, et al.
Published: (2020-12-01)

Comparison of homologous and heterologous vaccination strategies for combating disease caused by Burkholderia pseudomallei
by: Sergei S. Biryukov, et al.
Published: (2025-06-01)

Cytokine Storms and Anaphylaxis Following COVID-19 mRNA-LNP Vaccination: Mechanisms and Therapeutic Approaches
by: Toru Awaya, et al.
Published: (2024-10-01)

Pre-graft vaccination or infection do not decrease COVID-19 infections in recipients of allogeneic stem cell transplantation vaccinated and/or protected by immunotherapy after transplant
by: Valentin Letailleur, et al.
Published: (2024-12-01)

Post-COVID Versus Non-COVID Myocarditis: Comparison of Morphological Activity, Toll-like Receptor Distribution and Responses to Immunosuppressive Therapy
by: Olga V. Blagova, et al.
Published: (2025-06-01)

MYOCARDIAL BIOPSY IN GENERAL CARE CLINIC: PATIENTS SELECTION, THE RESULTS, SIGNIFICANCE FOR TREATMENT STRATEGY
by: O. V. Blagova, et al.
Published: (2015-05-01)

Safety and efficacy of RNA vaccines: State of the art
by: A. V. Blagov, et al.
Published: (2021-11-01)

Heterologous Omicron-adapted vaccine as a secondary booster promotes neutralizing antibodies against Omicron and its sub-lineages in mice
by: Jianyang Liu, et al.
Published: (2023-12-01)

Adverse events following the first, second and third doses of a COVID-19 vaccine in hemodialysis patients
by: Mei-Fen Pai, et al.
Published: (2023-12-01)

Development of mRNA rabies vaccines
by: Zixin Fang, et al.
Published: (2024-12-01)

Optimizing immunogenicity and product presentation of a SARS-CoV-2 subunit vaccine composition: effects of delivery route, heterologous regimens with self-amplifying RNA vaccines, and lyophilization
by: William R. Lykins, et al.
Published: (2024-12-01)

A goatpox but not sheeppox heterologous live attenuated vaccines provide complete protection against lumpy skin disease in cattle under experimental conditions
by: Andy Haegeman, et al.
Published: (2025-07-01)

Eosinophilic myocarditis in dilated cardiomyopathy: a case report
by: Mengxuan Li, et al.
Published: (2025-05-01)

CONTEMPORARY MASKS OF THE MYOCARDITIS (FROM CLINICAL SIGNS TO DIAGNOSIS)
by: O. V. Blagova, et al.
Published: (2014-05-01)

THE ROLE OF ENDOMYOCARDIAL BIOPSY IN DIAGNOSTICS OF INFLAMMATORY MYOCARDIUM DISEASES
by: L. B. Mitrofanova
Published: (2016-01-01)

Rationale for endomyocardial biopsy in the diagnosis of heart disease in children and adults
by: L. B. Mitrofanova, et al.
Published: (2021-12-01)

Rhinovirus as a rare cause of acute onset dilated cardiomyopathy due to myocarditis in a newborn: case report and review of the literature
by: Burcu Cebeci, et al.
Published: (2022-02-01)

Immune Imprinting, Non-Durable Hybrid Immunity, and Hybrid Immune Damping Following SARS-CoV-2 Primary Vaccination with BNT162b2 and Boosting with mRNA-1273
by: Alejo Erice, et al.
Published: (2025-03-01)

Heterologous prime–boost Zika virus vaccination induces comprehensive humoral and cellular immunity in mouse models
by: Giuditta De Lorenzo, et al.
Published: (2025-04-01)